» Articles » PMID: 3894172

Natural History of the HBsAg Carrier

Overview
Journal Gut
Specialty Gastroenterology
Date 1985 Aug 1
PMID 3894172
Citations 2
Authors
Affiliations
Soon will be listed here.
Citing Articles

Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.

Anderson M, Harrison T, Alexander G, Zuckerman A, Murray-Lyon I Gut. 1987; 28(5):619-22.

PMID: 3297940 PMC: 1432882. DOI: 10.1136/gut.28.5.619.


An acupuncture-associated outbreak of hepatitis B in Jerusalem.

Slater P, Leventhal A, Zahger D, Bashary A, Moses A, Costin C Eur J Epidemiol. 1988; 4(3):322-5.

PMID: 3181383 DOI: 10.1007/BF00148918.

References
1.
Obata H, Hayashi N, Motoike Y, Hisamitsu T, Okuda H, Kobayashi S . A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection. Int J Cancer. 1980; 25(6):741-7. DOI: 10.1002/ijc.2910250609. View

2.
Barker L, Murray R . Aquisition of hepatitis-associated antigen. Clinical features in young adults. JAMA. 1971; 216(12):1970-6. View

3.
Nielsen J, Dietrichson O, Elling P, Christoffersen P . Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis. N Engl J Med. 1971; 285(21):1157-60. DOI: 10.1056/NEJM197111182852101. View

4.
SINGLETON J, Merrill D, Fitch R, Kohler P, Rettberg W . Liver disease in Australia-antigen-positive blood-donors. Lancet. 1971; 2(7728):785-7. DOI: 10.1016/s0140-6736(71)92740-1. View

5.
Barker L, Murray R . Relationship of virus dose to incubation time of clinical hepatitis and time of appearance of hepatitis--associated antigen. Am J Med Sci. 1972; 263(1):27-33. DOI: 10.1097/00000441-197201000-00005. View